Johnson & Johnson on Tuesday boosted its full-year adjusted profit forecast, as multi-billion dollar sales of its cancer drugs Darzalex and Imbruvica helped it beat estimates for third-quarter profit.
Source:: Breaking News
J&J bumps up full-year profit view on strength of cancer drugs
More from Latest StoryMore posts in Latest Story »
- ‘She’s Absolutely Insufferable’: Chrissy Teigen Strikes a Chord with Angry Fans After Demanding Social Media Curfew While Half-Clothed In a Bath Towel
- ‘A Day Late and a Dollar Short’: Donald Trump’s Attempt to Embarrass Keisha Lance Bottoms with Online Dismissal Backfires As She Announces She Had Already Quit In Fiery Clap Back
- Concerned Fans Say Justin Bieber Is ‘Unraveling’ as He Shows Off His ‘Little Smokies’ In the Snow Days Before Unfollowing Wife Hailey Bieber on Instagram
- XO, Kitty Season 2: What to Expect from the New Chapter
- Rukmini Iyer’s quick and easy recipe for one-pan spaghetti puttanesca | Quick and easy
Be First to Comment